Efalizumab
Efalizumab, a novel potent regulator of T cells, is a humanized LFA-1 α subunit (CD11a) monoclonal antibody. Efalizumab has inhibitory effects on T cell activation, skin T cell transport, and T cell adhesion to keratinocytes, and can be used to study plaque psoriasis and psoriatic arthritis.
Product Specifications
CAS Number
214745-43-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Integrin
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
bsm-61980R-BF680-01 20 µL
P53 DINP1 Recombinant Antibody, AbBy Fluor™ 680 Conjugated
Ask
View Details bsm-61980R-BF680-02 100 µL
P53 DINP1 Recombinant Antibody, AbBy Fluor™ 680 Conjugated
Ask
View Details 
MBS7153977 Inquire
Rabbit anti-Oryza sativa subsp. japonica (Rice) RASI Polyclonal Antibody
Ask
View Details